Hatchtech inks $279m head lice deal as VC market comes to life
Australian pharmaceutical company Hatchtech has inked a deal worth up to $279 million with Indian giant Dr. Reddy’s for the commercialisation of its innovative head lice treatment.
Ventured. Gained.
Subscribe to our Newsletter.
